Latest Capital Expenditure News

Central Petroleum has swung to a $4.9 million FY2026 statutory loss after writing down two Amadeus Basin permits, but its gas business generated higher revenue and margins. The company is now betting on Palm Valley drilling, long-term contracts and new east coast acreage to restore growth.

Dyno Nobel has reaffirmed its FY26 outlook and retained its A$600 million FY28 underlying EBIT ambition, while setting a new A$800 million target for FY31. The explosives maker is positioning defence energetics, premium technology and growth in mining markets as the next leg of expansion.

Latrobe Magnesium has detailed the capital, feedstock and valuation assumptions behind its proposed 50 ktpa magnesium plant in South Carolina. The project retains strong headline economics, but funding, feasibility work and a final investment decision remain ahead.

Pan African Resources delivered record FY26 production, earnings and cash generation, moving from net debt to a US$185.7 million net cash position. The gold producer is proposing a record dividend and launching a ZAR500 million buy-back, while warning that FY27 costs will rise as it funds further growth.

Orezone Gold has outlined a 14-year plan for its newly acquired Casa Berardi mine, targeting 1.63 million ounces of production and an after-tax NPV of US$1.05 billion. The economics are substantial, but the plan remains a preliminary assessment built partly on Inferred Resources and requires significant capital and permitting work.

James Hardie has raised its FY27 Free Cash Flow target to at least US$600 million and expects to deliver its US$125 million cost synergy target roughly a year early. The company also outlined a 4% to 7% annual organic growth ambition above market, while targeting net leverage below 2.0x by Q2 FY28.

Infratil has raised FY27 earnings guidance as data-centre demand accelerates across CDC and Longroad, with AI infrastructure now representing 73% of its NZ$22 billion asset base. The company is also sharpening its strategy around scaled growth platforms, contracted cash flows and selective new investments.

PolyNovo delivered 16.1% revenue growth and a sharp improvement in operating cash flow in FY26, despite a lower statutory profit after a prior-year tax benefit and a fire-related write-off. The ASX-listed wound-care company now expects to lodge its U.S. PMA application for NovoSorb BTM before the end of 2026.

New Hope delivered more coal, expanded its resource base and declared a 30-cent final dividend, but lower realised prices and higher costs cut FY26 profit by 63.4%. The results leave investors weighing near-term earnings pressure against a larger production pipeline.

Meridian Energy’s generation rose 21.1% year on year in August as strong hydro and wind conditions pushed national storage to 155% of historical average. But average generation prices fell 62.3%, highlighting the tension between abundant supply and weaker market pricing.

ABx Group and its ALCORE subsidiary have received nearly $600,000 in R&D tax offsets, while ALCORE has completed repayment of $2.61 million in unused government grant funds. The company is now awaiting a decision on a separate Industry Growth Program application worth up to $5 million.

Kalamazoo Resources is moving Ashburton from exploration story to development proposition, backed by a positive Mt Olympus Scoping Study and extensive drilling. The next test is whether the updated resource, feasibility work and funding can turn the project’s preliminary economics into a mineable plan.